<?xml version="1.0" encoding="UTF-8"?>
<!-- Created with Liquid XML Studio - FREE Community Edition 7.0.1.654 (http://www.liquid-technologies.com) -->
<ONIXDOISerialArticleWorkRegistrationMessage xmlns="http://www.editeur.org/onix/DOIMetadata/2.0" xmlns:cl="http://www.medra.org/DOIMetadata/2.0/Citations" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.editeur.org/onix/DOIMetadata/2.0 http://www.medra.org/schema/onix/DOIMetadata/2.0/ONIX_DOIMetadata_2.0.xsd">
	<Header>
		<FromCompany>Institute of Chemistry of the Academy of Sciences of Moldova</FromCompany>
		<FromPerson>Larisa Postolachi</FromPerson>
		<FromEmail>chemjm_correspondence@yahoo.com</FromEmail>
		<ToCompany>mEDRA</ToCompany>
		<SentDate>20161225</SentDate>
	</Header>
	<DOISerialArticleWork xmlns="http://www.editeur.org/onix/DOIMetadata/2.0">
		<!-- in NotificationType field use value 06 for DOI creation. For DOI update use value 07.-->
		<NotificationType>07</NotificationType>
		<DOI>10.19261/cjm.2016.11(1).07</DOI>
		<DOIWebsiteLink>http://www.cjm.asm.md/sites/default/files/article_files/ChemJMold201611(1)_55-60_Daoudi.pdf</DOIWebsiteLink>
		<RegistrantName>Institute of Chemistry of the Academy of Sciences of Moldova</RegistrantName>
		<RegistrationAuthority>mEDRA</RegistrationAuthority>
		<SerialPublication>
			<SerialWork>
				<Title>
					<TitleType>01</TitleType>
					<TitleText>Chemistry Journal of Moldova</TitleText>
				</Title>
				<Title>
					<!--title type=05 means "abbreviated title" (optional)-->
					<TitleType>05</TitleType>
					<TitleText>ChemJMold</TitleText>
				</Title>
				<Publisher>
					<PublishingRole>01</PublishingRole>
					<PublisherName>Institute of Chemistry of the Academy of Sciences of Moldova</PublisherName>
				</Publisher>
				<CountryOfPublication>MD</CountryOfPublication>
			</SerialWork>
			<SerialVersion>
				<ProductIdentifier>
					<!-- if you have an ISSN for both print and electronic version of the journal, repeat the Serial Version composite to input both ISSNs-->
					<ProductIDType>07</ProductIDType>
					<!--print ISSN-->
					<IDValue>1857-1727</IDValue>
				</ProductIdentifier>
				<!--printed publication-->
				<ProductForm>JB</ProductForm>
			</SerialVersion>
			<SerialVersion>
				<ProductIdentifier>
					<ProductIDType>07</ProductIDType>
					<!--electronic ISSN-->
					<IDValue>2345-1688</IDValue>
				</ProductIdentifier>
				<!--electronic publication-->
				<ProductForm>JD</ProductForm>
			</SerialVersion>
		</SerialPublication>
		<JournalIssue>
			<JournalVolumeNumber>11</JournalVolumeNumber>
			<JournalIssueNumber>1</JournalIssueNumber>
			<JournalIssueDesignation>June 2016</JournalIssueDesignation>
			<JournalIssueDate>
				<!-- DateFormat=01 means YYYYMM-->				
				<DateFormat>01</DateFormat>
				<Date>201606</Date>
			</JournalIssueDate>
		</JournalIssue>
		<ContentItem>
			<SequenceNumber>7</SequenceNumber>
			<TextItem>
				<!-- 10=Serial item, miscellaneous or unspecified --> <!-- 11=Research article--> <!-- 12=Review --> <!-- 14=Short communication --> <!-- 18=Editorial --> 				
				<TextItemType>11</TextItemType>
				<PageRun>
					<FirstPageNumber>55</FirstPageNumber>
					<LastPageNumber>60</LastPageNumber>
				</PageRun>
				<NumberOfPages>6</NumberOfPages>
			</TextItem>
			<Title language="eng">
				<TitleType>01</TitleType>
				<TitleText>Synthesis and Antimicrobial Evaluation of Symmetrical Diquaternary Ammonium Salts Bearing Bis-1,3,4-Oxadiazole Rings Moieties</TitleText>
			</Title>
			<Contributor>
				<SequenceNumber>1</SequenceNumber>
				<!--contributor role=A01 means "author"-->				
				<ContributorRole>A01</ContributorRole>
				<PersonName>Sofiane Daoudi</PersonName>
				<PersonNameInverted>Daoudi, Sofiane</PersonNameInverted>
				<!--NamesBeforeKey + KeyNames is the preferred form for contributor name-->
				<NamesBeforeKey>Sofiane</NamesBeforeKey>
				<KeyNames>Daoudi</KeyNames>
			</Contributor>
			<!--to add more contributors repeat the group Contributor as many times as needed-->
			<Contributor>
				<SequenceNumber>2</SequenceNumber>
				<!--contributor role=A01 means "author"-->				
				<ContributorRole>A01</ContributorRole>
				<PersonName>Tahar Benaissa</PersonName>
				<PersonNameInverted>Benaissa, Tahar</PersonNameInverted>
				<!--NamesBeforeKey + KeyNames is the preferred form for contributor name-->
				<NamesBeforeKey>Tahar</NamesBeforeKey>
				<KeyNames>Benaissa</KeyNames>
			</Contributor>
			<Contributor>
				<SequenceNumber>3</SequenceNumber>
				<!--contributor role=A01 means "author"-->				
				<ContributorRole>A01</ContributorRole>
				<PersonName>Djallal Eddine Adli</PersonName>
				<PersonNameInverted>Adli, Djallal Eddine</PersonNameInverted>
				<!--NamesBeforeKey + KeyNames is the preferred form for contributor name-->
				<NamesBeforeKey>Djallal Eddine</NamesBeforeKey>
				<KeyNames>Adli</KeyNames>
			</Contributor>
			<Contributor>
				<SequenceNumber>4</SequenceNumber>
				<!--contributor role=A01 means "author"-->				
				<ContributorRole>A01</ContributorRole>
				<PersonName>Nisserine Hamini-Kadar</PersonName>
				<PersonNameInverted>Hamini-Kadar, Nisserine</PersonNameInverted>
				<!--NamesBeforeKey + KeyNames is the preferred form for contributor name-->
				<NamesBeforeKey>Nisserine</NamesBeforeKey>
				<KeyNames>Hamini-Kadar</KeyNames>
			</Contributor>
			<Language>
				<LanguageRole>01</LanguageRole>
				<LanguageCode>eng</LanguageCode>
			</Language>
			<Subject>
				<!-- 20 = Keywords optional -->
				<SubjectSchemeIdentifier>20</SubjectSchemeIdentifier>
				<!-- maximum length 100 characters -->
				<!--				1234567890123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890 -->				
				<SubjectHeadingText>1,3,4-oxadiazole; quaternary ammonium compounds; DMAEMA; DEAEMA; antimicrobial activities</SubjectHeadingText>
			</Subject>
			<OtherText>
				<!--abstract in english: optional 01=Main description-->
				<TextTypeCode>01</TextTypeCode>
				<Text language="eng">
					This study describes the synthesis of some novel compounds containing bis-1,3,4-oxadiazole bearing quaternary ammonium salt moieties. The newly synthesized compounds were evaluated for their antibacterial activity against various gram-positive and gram-negative strains of bacteria, and the antifungal activities were tested against three phytopathogenic fungi namely, Fusarium oxysporum, Fusarium commune and Fusarium rodelens.
				</Text>
			</OtherText>
			<PublicationDate>201606</PublicationDate>
			<CopyrightStatement>
				<CopyrightYear>2016</CopyrightYear>
				<!--<CopyrightOwner>
					<PersonName>Anna Lionetti</PersonName>
				</CopyrightOwner>-->
				<CopyrightOwner>
					<CorporateName>Institute of Chemistry of the Academy of Sciences of Moldova</CorporateName>
				</CopyrightOwner>		
			</CopyrightStatement>
			<cl:CitationList>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref01">
					<cl:DOI>10.1016/j.imbio.2011.08.004</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref02">
					<cl:DOI>10.1016/S2221-1691(12)60115-4</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref03">
					<cl:DOI>10.1016/j.transproceed.2014.08.032</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref04">
					<cl:DOI>10.1016/j.jgar.2015.02.005</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref05">
					<cl:DOI>10.1016/j.bmc.2011.12.049</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref06">
					<cl:DOI>10.1016/j.ejphar.2006.08.025</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref07">
					<cl:DOI>10.1016/j.bmc.2015.02.056</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref08">
					<cl:DOI>10.4236/pp.2013.43A003</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref09">
					<cl:DOI>10.1016/j.carbpol.2009.01.020</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref10">
					<cl:UnstructuredCitation>Kavitha, S.; Gnanavel, S.; Kannan, K. Biological aspects of 1,3,4-oxadiazole derivatives. Asian Journal of Pharmaceutical and Clinical Research, 2014, 7(4), pp. 11-20</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref11">
					<cl:UnstructuredCitation>Musmade, D.S.; Pattan, S.R.; Manjunath, S.Y. Oxadiazole a nucleus with versatile biological behaviour. International Journal of Pharmaceutical Chemistry, 2015, 5(1), pp. 11-20</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref12">
					<cl:DOI>10.1016/j.ejmech.2014.04.045</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref13">
					<cl:UnstructuredCitation>Shivi, B.; Monika, G. 1,3,4-Oxadiazole as antimicrobial agents: An overview. Journal of Chemical and Pharmaceutical Research, 2011, 3(3), pp. 137-147</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref14">
					<cl:DOI>10.1007/s00044-010-9335-0</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref15">
					<cl:DOI>10.2174/138955711797655407</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref16">
					<cl:DOI>10.1016/j.bmcl.2015.03.001</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref17">
					<cl:DOI>10.1016/j.bmcl.2014.09.086</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref18">
					<cl:DOI>10.1016/j.cbi.2009.07.014</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref19">
					<cl:DOI>10.1038/clpt.1983.170</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref20">
					<cl:DOI>10.1016/j.bmc.2013.08.002</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref21">
					<cl:UnstructuredCitation>Somani, R.R.; Balkund, V.D.; Nikam, S.R.; Shirodkar, P.Y.; Zope, D.B. Synthesis, antibacterial and anti-tubercular evaluation of some 1,3,4-oxadiazole based Mannich bases. International Journal of ChemTech Research, 2013, 5(5), pp. 2588-2592</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref22">
					<cl:UnstructuredCitation>Sayyed, A.T.; Elham, R.Z.; Hamed, R.; Bagher, A.; Bijan, S.; Majid, S.; Abbas, S.; Mehrdad, F. Evaluation of anxiolytic, sedative-hypnotic and amnesic effects of novel 2-phenoxy phenyl-1,3,4-oxadizole derivatives using experimental models. Iran Journal of Pharmaceutical Research, 2015, 14, pp. 51–57</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref23">
					<cl:DOI>10.1155/2014/694060</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref24">
					<cl:DOI>10.1002/9783527645640</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref25">
					<cl:DOI>10.1016/j.apsusc.2014.12.019</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref26">
					<cl:DOI>10.1002/(SICI)1097-4628(20000222)75:8&lt;1005::AID-APP5&gt;3.0.CO;2-W</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref27">
					<cl:DOI>10.1055/s-0028-1129654</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref28">
					<cl:DOI>10.1016/j.reactfunctpolym.2014.02.004</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref29">
					<cl:DOI>10.1016/j.reactfunctpolym.2015.02.005</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref30">
					<cl:UnstructuredCitation>Chamari, W.; Marianna, B.; Lívia, B.; Magdolna, E.S.; Ilona, P. Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation. Journal of Basic and Clinical Pharmacy, 2013, 4(3), pp. 73–75</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref31">
					<cl:DOI>10.1016/j.copbio.2015.03.018</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref32">
					<cl:DOI>10.1016/j.bmc.2015.05.055</cl:DOI>
				</cl:ArticleCitation>				
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref33">
					<cl:DOI>10.1016/j.reactfunctpolym.2014.10.002</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref34">
					<cl:DOI>10.1016/j.cclet.2011.01.030</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref35">
					<cl:DOI>10.1016/j.jsps.2013.04.004</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref36">
					<cl:UnstructuredCitation>Guo-Qiang, H.; Li-Li, H.; Guo-Qiang, W.; Nan-Nan, D.; Xiao-Yi, W.; Tie-Yao, C.; Jun, Y.; Wei, W.; SongQiang, X.; Wen-Long, H. Part IV: design, synthesis and antitumor activity of fluoroquinolone C-3 heterocycles: bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin. Acta Pharmaceutica Sinica, 2012, 47(8), pp. 1017−1022</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref37">
					<cl:UnstructuredCitation>Furniss, B.S.; Hannford, A.J.; Smith, P.W.G.; Tatchell, A.R. Vogel’s Text Book of Practical Organic Chemistry. John Wiley &amp; Sons: New York, 5th edition, 1989, pp. 1076</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref38">
					<cl:DOI>10.1016/j.reactfunctpolym.2007.01.008</cl:DOI>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref39">
					<cl:UnstructuredCitation>Reference method for brothdilution antifungal susceptibility testing of yeasts, Approved Standard, 2nd Edition, Clinical and Laboratory Standards Institute (USA), NCCLS document M27-A2, 2002, 22(15), 51p</cl:UnstructuredCitation>
				</cl:ArticleCitation>
				<cl:ArticleCitation key="10.19261/cjm.2016.11(1).07_ref40">
					<cl:UnstructuredCitation>Hamini, K.N.; Hamdane, F.; Boutoutaou, R.; Kihal, M.; Henni, J.E. Antifungal activity of clove (Syzygium aromaticum L.) Essential oil against phytopathogenic fungi of tomato (Solanum lycopersicum L.) in Algeria. Journal of Experimental Biology and Agricultural Sciences, 2014, 2(5), pp. 448-454</cl:UnstructuredCitation>
				</cl:ArticleCitation>
			</cl:CitationList>
		</ContentItem>
	</DOISerialArticleWork>
</ONIXDOISerialArticleWorkRegistrationMessage>